Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.97 USD | +6.10% | +6.94% | -1.70% |
May. 14 | Transcript : Belite Bio, Inc, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Belite Bio, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Belite Bio, Inc
Upcoming events on Belite Bio, Inc
Past events on Belite Bio, Inc
2024-05-14 04:30 pm | Q1 2024 Earnings Call |
2024-05-14 01:50 am | Q1 2024 Earnings Release |
2024-05-13 02:00 pm | Investor Meeting - Key Opinion Leader |
2024-05-05 06:45 pm | Association for Research in Vision and Ophthalmology Meeting - Dr. John Grigg |
2024-03-13 10:00 am | Leerink Partners Global Biopharma Conference |
2024-03-12 04:30 pm | Q4 2023 Earnings Call |
2024-03-11 09:27 pm | Q4 2023 Earnings Release |
2024-02-14 12:40 pm | Oppenheimer Healthcare Life Sciences Conference |
2023-12-06 | Benchmark Company Discovery Conference |
2023-11-27 03:00 pm | BTIG Ophthalmology Day |
2023-11-14 04:30 pm | Q3 2023 Earnings Call |
2023-11-13 08:15 pm | Q3 2023 Earnings Release |
2023-11-08 11:00 am | Deutsche Bank Depositary Receipts Virtual Investor Conference |
2023-11-05 06:57 pm | American Academy Of Ophthalmology Meeting |
2023-09-25 | Cantor Global Healthcare Conference |
2023-09-13 | H.C. Wainwright Global Investment Conference |
2023-08-09 04:30 pm | Q2 2023 Earnings Call |
2023-08-08 10:17 pm | Q2 2023 Earnings Release |
2023-05-11 08:00 am | Q1 2023 Earnings Call |
2023-05-09 | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -12,8 -13,5 5.27% | -31,7 -32,1 1.4% | -31,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,6 -13,4 5.88% | -31,6 -32,1 1.34% | -31,0 |
Net income Million USD | Released Forecast Spread | -9,67 | -12,6 -13,4 5.88% | -31,6 -32,8 3.64% | -31,4 |
EPS USD | Released Forecast Spread | -1,01 | -0,63 -0,66 3.82% | -1,19 -1,29 7.61% | -1,05 |
Announcement Date | 15/03/22 | 31/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -1,78 -4,03 55.78% | -1,78 -4,73 62.33% | -4,35 | -5,63 | -6,88 -5,02 -37.07% | -6,87 -7,41 7.32% | -11,0 -8,38 -30.8% | -6,98 -7,43 6.1% | -8,33 -7,50 -11.04% | -7,53 | -7,91 | -7,68 | -11,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,89 -5,02 -37.22% | -6,81 -7,41 8.16% | -10,9 -8,38 -30.47% | -6,99 -7,43 5.89% | -7,87 -7,50 -4.86% | -7,53 | -7,92 | -7,68 | -11,5 |
Net income Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,90 -5,02 -37.34% | -6,81 -7,44 8.38% | -10,9 -8,79 -24.47% | -6,99 -8,20 14.78% | -7,87 -8,45 6.85% | -7,68 | -8,01 | -7,96 | -11,5 |
EPS USD | Released Forecast Spread | -0,12 -0,29 57.89% | -0,12 -0,24 48.94% | -0,18 | -0,23 | -0,33 -0,20 -65% | -0,26 -0,30 12.61% | -0,40 -0,32 -25% | -0,24 -0,30 20% | -0,27 -0,29 5.26% | -0,26 | -0,26 | -0,26 | -0,33 |
Announcement Date | 11/08/22 | 11/08/22 | - | - | 10/05/23 | 09/08/23 | 14/11/23 | 12/03/24 | 14/05/24 | - | - | - | - |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Belite Bio, Inc
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLTE Stock
- Calendar Belite Bio, Inc